The board


Tormod Fladby

Fladby is Professor at the Department of Clinical Medicine (UiO) and Akershus University Hospital. He is doing research on pre-dementia and early diagnosis of dementia.




Board Members

Håkon Sæterøy

Sæterøy is Managing Director of INVESTOR Corporate AS, CEO of Pre Diagnostics and Senior Corporate Finance Advisor with VL Corporate AS. He was Chairman of NNN from 2010 – 2012 and Chairman of DiaGenic ASA from 2002 – 2010. Sæterøy is a board member of Oslo Cancer Cluster and shareholder and board member of several life science companies in Norway. He has a Master of Science in Business from NHH in Bergen, and more than 25 years of experience within Corporate Finance.


Linda Hildegard Bergersen

Bergersen is associate professor and head of the Brain and Muscle Energy Group, University of Oslo. She is also a Professor in Neurobiology at the Department of Neuroscience and Pharmacology and Guest Professor at the Centre for Healthy Aging, University of Copenhagen.


Ole Kristian Hjelstuen

Hjelstuen is CEO of Inven2, the Technology Transfer Office for the University of Oslo and the South-Eastern Health Region of Norway. He comes from the position as VP R&D of GE Healthcare, and has broad experience in global industrial research and product development in Life Science. He has been an associate professor in pharmaceutics at the University of Tromsø since 2000.


Leif Rune Skymoen

Skymoen is former CEO of NNN and now CEO of the Norwegian Contract and Development Manufacturing Organization, Curida. 



Halvard Grønlien

Medical Affairs Manager , Abbvie



Pål Romundstad

Romundstad is the Vice Dean for Research at the Faculty of Medicine and Professor of Epidemiology at the Department of Public Health and General Practice at NTNU (Norwegian University of Science and Technology)



Beatrix Vereijken

 Professor ,Department of Neuroscience at NTNU



Anne Rita Øksengård

Dr. Med. Head of research, the National Association
for Public Health